Entry Detail



General Information

Database ID:exR0005232
RNA Name:FLNA
RNA Type:mRNA
Chromosome:chrX
Starnd:-
Coordinate:
Start Site(bp):154348524End Site(bp):154374638
External Links:ENSG00000196924



Disease Information

Disease Name:Down Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D004314
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Syndrome, Down//Mongolism//47,XY,+21//Trisomy G//47,XX,+21//Down's Syndrome//Downs Syndrome//Syndrome, Down's//Trisomy 21//Trisomy 21, Mitotic Nondisjunction//Down Syndrome, Partial Trisomy 21//Partial Trisomy 21 Down Syndrome//Trisomy 21, Meiotic Nondisjunction



Expression Detail

GEO ID:GSE16176
Description:Expression profiles of amniotic fluid from human fetuses with Down syndrome and euploid controls
Experimental Design:Disease vs Control
Case Disease Type:Down Syndrome
Case Disease SubType:NA
Case Sample:Down Syndrome
Control Sample:Normal
Number of Case:7
Number of Control:7
Number of Samples:14





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AATF
chr17
36948954
37056871
+
ABCA2
chr9
137007234
137028922
-
ABHD17A
chr19
1876810
1885547
-
AC008403.1
chr19
48465837
48472431
+
AC008982.1
chr19
38817471
38840178
-
AC027644.4
chr7
66628958
66811189
+
AC138969.1
chr16
16317444
16350590
+
AC233992.2
chr8
144353228
144355609
-
AC245033.1
chr15
82536788
82573194
-
ACIN1
chr14
23058564
23095614
-
ACTB
chr7
5527148
5563784
-
ADAMTS1
chr21
26835755
26845409
-
ADAMTS19
chr5
129460281
129738683
+
ADAMTSL4
chr1
150549369
150560937
+
ADCY3
chr2
24819169
24919839
-
ADCY6
chr12
48766194
48789037
-
ADGRE5
chr19
14380501
14408725
+
ADIPOR1
chr1
202940826
202958572
-
ADNP2
chr18
80109262
80147523
+
AFDN
chr6
167826922
167972023
+
AFG3L2
chr18
12328944
12377227
-
AFMID
chr17
78187317
78207701
+
AGO2
chr8
140520156
140635633
-
AGPAT1
chr6
32168212
32178096
-
AGRN
chr1
1020120
1056118
+
AIP
chr11
67483026
67491103
+
AK4
chr1
65147549
65232145
+
AKT2
chr19
40230317
40285536
-
AL807752.6
chr9
137031241
137040436
-
ALDH7A1
chr5
126531200
126595362
-
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-103a-3p
chr5
168560904
168560926
-
hsa-miR-5100
chr10
42997630
42997651
+
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC015961.2
chr18
37243776
37247506
+
AC026362.1
chr12
122975320
122982907
+
AC079781.5
chr7
97851688
97972985
-
AD000090.1
chr19
35557956
35581954
+
AL021707.2
chr22
38667585
38681847
-
AL137127.1
chr1
19072110
19075511
-
Display:



Experiment Detail

GEO ID:GSE16176
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:NA
RNA Extract protocol:RNA was extracted from 10 mL AF with 30 mL TRIzol LS Reagent (Invitrogen, Carlsbad, CA) and 8 mL chloroform. After RNA extraction, RNA was purified and DNA was removed using the RNeasy® Maxi Kit, including the DNase step according to the manufacturer's protocol (QIAGEN, Valencia, CA). RNA was precipitated using 3M NaOAc and 100% ethanol, and 80% ethanol was added after 4 hours incubation at -20 °C. cDNA, synthesized from extracted RNA, was amplified and purified using the WT-Ovation™ Pico RNA Amplification System (NuGEN, San Carlos, CA) and the DNA Clean & Concentrator™-25 (Zymo Research, Orange, CA).
RNA library preparation protocol:biotin Samples were labeled using the FL-Ovation™ cDNA Biotin Module V2 (NuGEN, San Carlos, CA).



Reference

PMID:19474297
Title:Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses
Author:Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Bianchi DW
Journal:Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9425-9.
Description:To characterize the differences between second trimester Down syndrome (DS) and euploid fetuses, we used Affymetrix microarrays to compare gene expression in uncultured amniotic fluid supernatant samples.